The accumulation of protoporphyrin IX in plaque psoriasis after topical application of 5-aminolevulinic acid indicates a potential for superficial photodynamic therapy

Journal of Investigative Dermatology

Volumn 107, Issue 1, 1996, Pages 76-81

  Stringer, Mark R ^a   Collins, Paul ^b   Robinson, Dominic J ^a   Stables, Graeme I ^b   Sheehan Dare, Robert A ^b  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

Fluorescence; Photosensitization

Indexed keywords

AMINOLEVULINIC ACID; PROTOPORPHYRIN;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG TISSUE LEVEL; FLUORESCENCE; HUMAN; HUMAN TISSUE; PHOTODYNAMIC THERAPY; PHOTOSENSITIZATION; PRIORITY JOURNAL; PSORIASIS; TREATMENT OUTCOME;

EID: 0030036822     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1111/1523-1747.ep12298282     Document Type: Article

References (13)

1. Berns MW, Rettenmaier M, McCullough J, Coffey J, Wile A, Berman M, Disaia P, Weinstein G: Response of psoriasis to red laser light (630 nm) following systemic injection of haematoporphyrin derivative. Lasers Surg Med 4:73-77, 1984
2. Boehncke WH, Konig K, Kauffmann R, Scheffold W, Prummer O, Sterry W: Photodynamic therapy in psoriasis: suppression of cytokine production in vitro and recording of fluorescence modification during treatment in vivo. Arch Dermatol Res 286:300-303, 1994a
3. Boehncke WH, Sterry W, Kauffmann R: Treatment of psoriasis by topical photodynamic therapy with polychromatic light. The Lancet 343:801, 1994b
4. Cairnduff F, Stringer MR, Hudson EJ, Ash DV, Brown SB: Superficial photodynamic therapy with topical 5-aminolaevulinic acid for superficial primary and secondary skin cancer. Br J Cancer 69:605-608, 1994
5. Fijan S, Honigsmann H, Ortel B: Photodynamic therapy of epithelial skin tumours using delta-aminolaevulinic acid and desferrioxamine. Br J Dermatol 133:282-288, 1995
6. Grannon MJ, Johnson N, Roberts DJH, Holroyd JA, Vernon DI, Brown SB, Lilford RJ: Photosensitization of the endometrium using topical 5-aminolevulinic acid. Am J Obstet Gynecol 173:1826-1828, 1995
7. Kennedy JC, Pottier RH, Pross DC: Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. J Photochem Photobiol B 6:143-148, 1990
8. Kennedy JC, Pottier RH: Endogenous protoporphyrin IX, a clinically useful photosensitiser for photodynamic therapy. J Photochem Photobiol B 14:275-292, 1992
9. Loh CS, MacRobert AJ, Bedwell J, Regula J, Krasner N, Brown SG: Oral versus intravenous administration of 5-aminolaevulinic acid for photodynamic therapy. Br J Cancer 68:41-51, 1993
10. Meffert H, Pres H, Diezel W, Sonnichsen N: Anti-psoriasis and phototoxic effect of haematoporphyrin derivative following topical administration followed by irradiation with visible light. Dermatologische Monatsschrifi 175:28-34, 1989
11. Silver H: Psoriasis vulgaris treated with haematoporphyrin. Arch Dermatol Syphiol 36:1118-1119, 1937
12. Svanberg K, Andersson T, Killander D, Wang I, Stenram U, Andersson-Engels S, Berg R, Johansson J, Svanberg S: Photodynamic therapy of non-melanoma malignant tumours of the skin using topical δ-amino levulinic acid sensitization and laser irradiation. Br J Dermatol 130:743-731, 1994
13. Wolf P, Rieger E, Kerl H: Topical photodynamic therapy with endogenous porphyrins after application of 5-aminolevulinic acid. J Am Acad Dematol 28:17-21, 1993